Abstract
The effective management of odontogenic keratocyst (OKC) remains a subject of interest and confusion in the oral and maxillofacial surgery literature. Currently, there is a lack of consensus regarding the most appropriate treatment for patients with OKC. Of the various treatment options available, no modality to date has been shown to demonstrate a zero or near-zero recurrence rates except wide resection with clear margins. With the prevailing dearth of evidence based surgical protocols for the management of patients with OKC in the literature, this study aims to present a surgical algorithm, based on meta-analysis results, that hopefully will be beneficial in enhancing treatment of patients with this condition. Also, new meta-analysis was done to compare between modified Carnoy’s solution (MCS) and 5-fluorouracil (5-FU) in respect of recurrence rate of OKC. Using parameters like size, lesion type (primary or secondary), syndromic or solitary nature of the lesion, presence of cortical perforations, and locularity; we present a decision tree, to aid treatment planning and help attain the least chance of recurrence in the management of the OKC. There was very low-quality evidence indicating that application of 5-FU, after enucleation and peripheral ostectomy of OKCs, significantly lowered recurrence rate when compared to MCS (RR = 0.087, CI: 0.017 to 0.436, P value = 0.003).
Similar content being viewed by others
References
Speight P, Devilliers P, Li TJ, Odell EW, Wright JM (2017) Odontogenic keratocyst. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC, Lyon, pp 235–236
Nayak MT, Singh A, Singhvi A, Sharma R (2013) Odontogenic keratocyst: what is in the name? J Nat Sci Biol Med 4:282–285. https://doi.org/10.4103/0976-9668.116968
Stoelinga PJ, Bronkhorst FB (1988) The incidence, multiple presentation and recurrence of aggressive cysts of the jaws. J. Craniomaxillofac Surg. 16:184–95. https://doi.org/10.1016/s1010-5182(88)80044-1
Rogerson KC (1991) Gorlin’s syndrome: an update on diagnosis and management. Oral Maxillofac Clin North Am 3:155
Williams TP (1991) Surgical treatment of odontogenic keratocysts. Oral Maxillofac Clin North Am 3:137
Ghali GE, Connor MS (2003) Surgical management of the odontogenic keratocyst. Oral Maxillofac Surg Clin. 15:383–92. https://doi.org/10.1016/S1042-3699(03)00042-6
Kolokythas A, Fernandes RP, Pazoki A, Ord RA (2007) Odontogenic keratocyst: to decompress or not to decompress? A comparative study of decompression and enucleation versus resection/peripheral ostectomy. J Oral Maxillofac Surg 65:640–644. https://doi.org/10.1016/j.joms.2006.06.284
Kinard BE, Chuang SK, August M, Dodson TB (2015) For treatment of odontogenic keratocysts, is enucleation, when compared to decompression, a less complex management protocol? J Oral Maxillofac Surg 73:641–648. https://doi.org/10.1016/j.joms.2014.11.001
Al-Moraissi EA, Dahan AA, Alwadeai MS, Oginni FO, Al-Jamali JM, Alkhutari AS et al (2017) What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: a large systematic review and meta-analysis. J Craniomaxillofac Surg 45:131–144. https://doi.org/10.1016/j.jcms.2016.10.013
Al-Moraissi EA, Pogrel MA, Ellis E (2016) Enucleation with or without adjuvant therapy versus marsupialization with or without secondary enucleation in the treatment of keratocystic odontogenic tumors: a systematic review and meta-analysis. J Craniomaxillofac Surg 44:1395–1403. https://doi.org/10.1016/j.jcms.2016.05.020
Al-Moraissi EA, Pogrel MA, Ellis E (2016) Does the excision of overlying oral mucosa reduce the recurrence rate in the treatment of the keratocystic odontogenic tumor? A systematic review and meta-analysis. J Oral Maxillofac Surg 74:1974–1982. https://doi.org/10.1016/j.joms.2016.03.043
Gosau M, Draenert F, Muller S et al (2010) Two modifications in the treatment of keratocystic odontogenic tumors (KCOT) and the use of Carnoy’s solution (CS)—a retrospective study lasting between 2 and 10 years. Clin Oral Investig 14:27–34
Pitak-Arnnop P, Chaine A, Oprean N, Dhanuthai K, Bertrand JC, Bertolus C (2010) Management of odontogenic keratocysts of the jaws: a ten-year experience with 120 consecutive lesions. J Craniomaxillofac Surg 2010(38):358–364. https://doi.org/10.1016/j.jcms.2009.10.006
Schmidt B, Pogrel M (2001) The use of enucleation and liquid nitrogen cryotherapy in the management of odontogenic keratocysts. J Oral Maxillofac Surg 59:720–725
Blanas N, Freund B, Schwartz M et al (2000) Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:553–558
Ribeiro Junior O, Borba A, Alves C et al (2012) Keratocystic odontogenic tumors and Carnoy’s solution: results and complications assessment. Oral Dis 2012(18):548–557
Dashow J, McHugh J, Braun T et al (2015) Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy’s versus modified Carnoy’s solution. J Oral Maxillofac Surg 73:2132–2135
Frerich B, Cornelius C, Weitholter H (1994) Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy’s solution. J Oral Maxillofac Surg 52:599–606
Beach D, Somer R (2011) Novel approach to Gorlin syndrome: a patient treated with oral capecitabine. J Clin Oncol 29:e397-401
Ren C, Amm H, DeVilliers P et al (2012) Targeting the sonic hedgehog pathway in keratocystic odontogenic tumor. J Biol Chem 287:27117–27125
Rui Z, Li-Ying P, Jia-Fei Q et al (2014) Smoothened gene alterations in keratocystic odontogenic tumors. Head Face Med 10:1–7
Zhang L, Sun Z, Zhao Y et al (2006) Inhibition of SHH signaling pathway: molecular treatment strategy of odontogenic keratocyst. Med Hypotheses 67:1242–1244
Booms P, Harth M, Sader R et al (2015) Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome. Ann Maxillofac Surg 5:14
Wang Q, Huang S, Yang L et al (2008) Down-regulation of sonic hedgehog signaling pathway activity is involved in 5-fluorouracil induced apoptosis and motility inhibition in Hep3B cells. Acta Biochim Biophys Sin 40:819–829
Gross K, Kircik L, Kricorian G (2007) 5% 5-fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 33:433–440
Ledderhof NJ, Caminiti MF, Bradley G, Lam DK (2017) Topical 5-fluorouracil is a novel targeted therapy for the keratocystic odontogenic tumor. J Oral Maxillofac Surg 75:514–524
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2006) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
Caminiti MF, El-Rabbany M, Jeon J, Bradley G (2021) 5-fluorouracil is associated with a decreased recurrence risk in odontogenic keratocyst management: a retrospective 15 cohort study. J Oral Maxillofac Surg 79:814–821
Akhter LP, Ahmed WN, Ahmed JZ, Bibi M, Kour A (2020) Topical 5-fluorouracil application in management of odontogenic keratocysts. J Oral Biol Craniofacial Res 10:404–406
Ledderhof NJ, Caminiti MF, Bradley G, Lam DK (2017) Topical 5-fluorouracil is a novel targeted therapy for the keratocystic odontogenic tumor. J Oral Maxillofac Surg 75(3):514–524
Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A et al (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841–51. https://doi.org/10.1016/s0092-8674(00)81268-4
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM et al (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668–71. https://doi.org/10.1126/science.272.5268.1668
Lench NJ, Telford EA, High AS, Markham AF, Wicking C, Wainwright BJ (1997) Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Hum Genet. 100:497–502. https://doi.org/10.1007/s004390050541
Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L (2000) PTCH gene mutations in odontogenic keratocysts. J. Dent. Res. 79:1418–22. https://doi.org/10.1177/00220345000790061101
Agaram NP, Collins BM, Barnes L, Lomago D, Aldeeb D, Swalsky P et al (2004) Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 128:313–317
Cohen MM Jr (1999) Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. Int J Oral Maxillofac Surg 28:216–223. https://doi.org/10.1016/S0901-5027(99)80142-8
Lench NJ, High AS, Markham AF, Hume WJ, Robinson PA (1996) Investigation of chromosome 9q22.3-q31 DNA marker loss in odontogenic keratocysts. Eur. J. Cancer. B. Oral Oncol. 32:202–6. https://doi.org/10.1016/0964-1955(95)00053-4
Levanat S, Pavelić B, Crnić I, Orešković S, Manojlović S (2000) Involvement of PTCH gene in various noninflammatory cysts. J Mol Med 78:140–146. https://doi.org/10.1007/s001090000090
Pavelić B, Levanat S, Crnić I, Kobler P, Anić I, Manojlović S et al (2001) PTCH gene altered in dentigerous cysts. J Oral Pathol Med 30:569–76. https://doi.org/10.1034/j.1600-0714.2001.300911.x
Li TJ (2011) The odontogenic keratocyst: a cyst, or a cystic neoplasm? J. Dent. Res. 90:133–42. https://doi.org/10.1177/0022034510379016
Qu J, Yu F, Hong Y, Guo Y, Sun L, Li X et al (2015) Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors. Oral Oncol. 51:40–5. https://doi.org/10.1016/j.oraloncology.2014.09.016
Pogrel MA, Jordan RCK (2004) Marsupialization as a definitive treatment for the odontogenic keratocyst. J Oral Maxillofac Surg 62:651–655. https://doi.org/10.1016/j.joms.2003.08.029
Wushou A, Zhao YJ, Shao ZM (2014) Marsupialization is the optimal treatment approach for keratocystic odontogenic tumour. J Craniomaxillofac Surg 42:1540–1544. https://doi.org/10.1016/j.jcms.2014.04.027
Shear M, Speight PM (2007) Cysts of the oral and maxillofacial regions, 4th edn. Blackwell Munksgaard, Oxford
Scholl RJ, Kellett HM, Neumann DP, Lurie AG (1999) Cysts and cystic lesions of the mandible: clinical and radiologic-histopathologic review. Radiogr Rev Publ Radiol Soc N Am Inc 19:1107–24. https://doi.org/10.1148/radiographics.19.5.g99se021107
Dunfee BL, Sakai O, Pistey R, Gohel A (2006) Radiologic and pathologic characteristics of benign and malignant lesions of the mandible. Radiogr Rev Publ Radiol Soc N Am Inc 26:1751–68. https://doi.org/10.1148/rg.266055189
Nazir H, Latoo S (2015) Cystic fliud–pathway to enlighten the early diagnosis of keratocystic odontogenic tumor. Sch J App Med Sci 2015(3):2466–2469
Patidar M, Shetty P, Patidar N, Mittal S, Singh H, Chethna A (2015) Biochemical and cytological comparison of keratocystic odontogenic tumours to nonkeratinising odontogenic cysts fluid. J. Clin Diagn Res. 9:ZC34–ZC38. https://doi.org/10.7860/JCDR/2015/12501.6195
Prakash R, Shyamala K, Girish HC, Murgod S, Singh S, Rani PSV (2016) Comparison of components of odontogenic cyst fluids: a review. J Med Radiol Pathol Surg 2:15–17. https://doi.org/10.15713/ins.jmrps.51
Pindborg JJ, Hansen J (1963) Studies on odontogenic cyst epithelium 2: clinical and roentgenologic aspects of odontogenic keratocysts. Acta Pathol Microbiol Scand 58:283–294. https://doi.org/10.1111/j.1699-0463.1963.tb01572.x
Minami M, Kaneda T, Ozawa K, Yamamoto H, Itai Y, Ozawa M et al (1996) Cystic lesions of the maxillomandibular region: MR imaging distinction of odontogenic keratocysts and ameloblastomas from other cysts. AJR Am J Roentgenol 166:943–949. https://doi.org/10.2214/ajr.166.4.8610578
van Rensburg LJ, Paquette M, Morkel JA, Nortjé CJ (2003) Correlative MRI and CT imaging of the odontogenic keratocyst: a review of twenty-one cases. Oral Maxillofac Surg Clin N Am 15:363–382. https://doi.org/10.1016/S1042-3699(03)00037-2
Asaumi J, Yanagi Y, Konouchi H, Hisatomi M, Matsuzaki H, Shigehara H et al (2004) Assessment of MRI and dynamic contrast-enhanced MRI in the differential diagnosis of adenomatoid odontogenic tumor. Eur J Radiol 51:252–256. https://doi.org/10.1016/j.ejrad.2003.09.009
Probst FA, Probst M, Pautke C, Kaltsi E, Otto S, Schiel S et al (2015) Magnetic resonance imaging: a useful tool to distinguish between keratocystic odontogenic tumours and odontogenic cysts. Br J Oral Maxillofac Surg 53:217–222. https://doi.org/10.1016/j.bjoms.2014.10.014
Aronovich S, Kim RY (2014) The sensitivity and specificity of frozen-section histopathology in the management of benign oral and maxillofacial lesions. J Oral Maxillofac Surg 72:914–919. https://doi.org/10.1016/j.joms.2013.10.022
Eida S, Hotokezaka Y, Katayama I, Ichikawa Y, Tashiro S, Sumi T et al (2012) Apparent diffusion coefficient-based differentiation of cystic lesions of the mandible. Oral Radiol 28:109–114. https://doi.org/10.1007/s11282-012-0095-z
Guthrie D, Peacock ZS, Sadow P, Dodson TB, August M (2012) Preoperative incisional and intraoperative frozen section biopsy techniques have comparable accuracy in the diagnosis of benign intraosseous jaw pathology. J Oral Maxillofac Surg 70:2566–2572. https://doi.org/10.1016/j.joms.2011.11.023
Gadbail AR, Chaudhary M, Patil S, Gawande M (2009) Actual proliferating index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis 15:490–498. https://doi.org/10.1111/j.1601-0825.2009.01590.x
Selvi F, Tekkesin MS, Cakarer S, Isler SC, Keskin C (2012) Keratocystic odontogenic tumors: predictive factors of recurrence by Ki-67 and AgNOR labelling. Int J Med Sci 9(4):262–268. https://doi.org/10.7150/ijms.4243
Vered M, Shohat I, Buchner A, Dayan D (2005) Myofibroblasts in the stroma of odontogenic cysts and tumors can contribute to variations in the biologic behavior of lesions. Oral Oncol 4(41):1028–1033. https://doi.org/10.1016/j.oraloncology.2005.06.011
Karaca Ç, Dere KA, Er N, Aktaş A, Tosun E, Köseoğlu OT et al (2018) Recurrence rate of odontogenic keratocyst treated by enucleation and peripheral ostectomy: retrospective case series with up to 12 years of follow-up. Med Oral Patol Oral Cir Bucal. 23:443–8. https://doi.org/10.4317/medoral.22366
Stoelinga PJ (2001) Long-term follow-up on keratocysts treated according to a defined protocol. Int J Oral Maxillofac Surg 30:14–25. https://doi.org/10.1054/ijom.2000.0027
Stoelinga PJ, Bronkhors FB (1988) The incidence, multiple presentation and recurrence of aggressive cysts of the jaws. J CranioMaxillofac Surg 16:184–195. https://doi.org/10.1016/s1010-5182(88)80044-1
Rodu B, Tate AL, Martinez MG (1987) The implications of inflammation in odontogenic keratocysts. J Oral Pathol Med 16:518–521. https://doi.org/10.1111/j.1600-0714.1987.tb00684.x
August M, Faquin WC, Troulis M, Kaban LB (2000) Differentiation of odontogenic keratocysts from nonkeratinizing cysts by use of fine-needle aspiration biopsy and cytokeratin-10 staining. J Oral Maxillofac Surg 58:935–940. https://doi.org/10.1053/joms.2000.8731
Pogrel MA (2013) The keratocystic odontogenic tumor. Oral Maxillofac Surg Clin 25:21–30. https://doi.org/10.1016/j.coms.2012.11.003
Sumi M, Ichikawa Y, Katayama I, Tashiro S, Nakamura T (2008) Diffusion-weighted MR imaging of ameloblastomas and keratocystic odontogenic tumors: differentiation by apparent diffusion coefficients of cystic lesions. AJNR Am J Neuroradiol 29:1897–1901. https://doi.org/10.3174/ajnr.A1266
Chapelle KA, Stoelinga PJ, de Wilde PC, Brouns JJ, Voorsmit RA (2004) Rational approach to diagnosis and treatment of ameloblastomas and odontogenic keratocysts. Br J Oral Maxillofac Surg 42:381–390. https://doi.org/10.1016/j.bjoms.2004.04.005
Fidele NB, Yueyu Z, Zhao Y, Tianfu W, Liu J, Sun Y, Liu B (2019) Recurrence of odontogenic keratocysts and possible prognostic factors: review of 455 patients. Med Oral Patol Oral Cir Bucal 24(4):e483–e490
Cunha JF, Gomes CC, de Mesquita RA, Andrade Goulart EM, de Castro WH, Gomez RS (2016) Clinicopathologic features associated with recurrence of the odontogenic keratocyst: a cohort retrospective analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 121(6):629–635. https://doi.org/10.1016/j.oooo.2016.01.015 (Epub 2016 Jan 29 PMID: 27050804)
Berge TI, Helland SB, Saelen A, Oren M, Johannessen AC, Skartveit L et al (2016) Pattern of recurrence of nonsyndromic keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol 122:10–16. https://doi.org/10.1016/j.oooo.2016.01.004
Stoelinga PJ (2005) The treatment of odontogenic keratocysts by excision of the overlying, attached mucosa, enucleation, and treatment of the bony defect with Carnoy solution. J Oral Maxillofac Surg 63:1662–1666. https://doi.org/10.1016/j.joms.2005.08.007
Pogrel MA (2015) The keratocystic odontogenic tumour (KCOT)—an odyssey. Int J Oral Maxillofac Surg 44:1565–1568. https://doi.org/10.1016/j.ijom.2015.03.008
Ally MS, Tang JY, Joseph T, Thompson B, Lindgren J, Raphael MA et al (2014) The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome. JAMA Dermatol 150(5):542. https://doi.org/10.1001/jamadermatol.2013.7444
Donnelly LA, Simmons TH, Blitstein BJ, Pham MH, Saha PT, Phillips C et al (2021) Modified carnoy's compared to carnoy's solution Is equally effective in preventing recurrence of odontogenic keratocysts. J Oral Maxillofac Surg 79:1874–81
Dashow JE, McHugh JB, Braun TM, Edwards SP, Helman JI, Ward BB (2015) Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using carnoy's versus modified carnoy's solution. J Oral Maxillofac Surg 73:2132–5
Author information
Authors and Affiliations
Contributions
Study conception, design, data collection, and analysis were performed by Essam Al-Moraissi. All authors contributed to data collection and manuscript write up. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not required.
Informed consent
Not required.
Consent to participate
Not required.
Consent for publication
Not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Oginni, F., Alasseri, N., Ogundana, O. et al. An evidence-based surgical algorithm for management of odontogenic keratocyst. Oral Maxillofac Surg 27, 201–212 (2023). https://doi.org/10.1007/s10006-022-01064-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-022-01064-z